Charles Conway

Professor of Psychiatry

Additional Titles & Roles

  • Director, Treatment Resistant Depression and Neurostimulation Clinic
  • Director, Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders (CARRMA)
  • Interventional Psychiatry Rotation Director

Education & Training

  • Residency: Duke University, Durham, NC, 1999
  • MD: University of Missouri, Columbia, MO, 1995
  • BA: Biology: St. Louis University, St. Louis, MO, 1987
  • BA: Psychology: St. Louis University, St. Louis, MO, 1987

Major Awards

  • Ziskind-Somerfeld Research Award, Society of Biological Psychiatry, 2016
  • Best Doctors in America, (Best Doctors, Inc.), 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019
  • Resident Faculty Teaching Award, Washington University, 2014
  • Resident Mentor Award, Washington University, 2011
  • NARSAD Sidney Baer Award, 2007
  • Resident Faculty Teaching Award, St. Louis University, 2004, 2007

Areas of Clinical Interest

mood disorders, treatment-resistant mood disorders, bipolar disorders

Research Interests

treatment-resistant depression (TRD) phenomenology, novel treatments for TRD, neuroimaging of mood disorders, bipolar disorders

Visit lab website

Key Publications

See more publications

Funded Research Projects

Lead Investigator for RECOVER national trial: A prospective, multicenter, randomized controlled, blinded trial demonstrating the safety and efficacy of Vagus Nerve Stimulation as an adjunctive therapy versus a no stimulation control in subjects with treatment-resistant depression.

American Foundation of Suicide Prevention (Co-PI). Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients.

Brain and Behavior Research Foundation (Co-I). Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies.

NIMH R21 (Co-PI). Targeting Affective Circuits Using the N-methyl-D-Aspartate (NMDA) Antagonist Nitrous Oxide.

Taylor Family Institute for Innovative Psychiatric Research (PI): Biological and Psychological Phenomenology Studies of Treatment-Resistant Depressive Disorder.